CME Group (NASDAQ:CME) PT Raised to $191.00 at JPMorgan Chase & Co.

CME Group (NASDAQ:CME) had its price objective hoisted by JPMorgan Chase & Co. from $187.00 to $191.00 in a research note published on Thursday, Benzinga reports. The firm currently has an underweight rating on the financial services provider’s stock.

Other equities analysts have also issued research reports about the stock. Morgan Stanley boosted their price target on shares of CME Group from $222.00 to $225.00 and gave the company an equal weight rating in a report on Tuesday, April 9th. Barclays increased their price target on CME Group from $208.00 to $209.00 and gave the stock an equal weight rating in a report on Thursday. Keefe, Bruyette & Woods raised their price target on CME Group from $212.00 to $213.00 and gave the stock a market perform rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a hold rating and issued a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Piper Sandler dropped their target price on shares of CME Group from $235.00 to $225.00 and set an overweight rating on the stock in a report on Thursday. Three analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of Hold and a consensus price target of $212.64.

CME Group Price Performance

CME Group stock opened at $200.54 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $72.21 billion, a P/E ratio of 22.81, a PEG ratio of 6.65 and a beta of 0.52. The business has a 50-day moving average of $199.87 and a 200-day moving average of $207.06. CME Group has a 1 year low of $190.70 and a 1 year high of $223.80.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm earned $2.30 EPS. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, equities analysts anticipate that CME Group will post 9.8 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were issued a $1.15 dividend. The ex-dividend date was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.29%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Transactions at CME Group

In other news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares in the company, valued at approximately $2,821,771.52. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel R. Glickman sold 650 shares of the stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The disclosure for this sale can be found here. Insiders have sold a total of 14,290 shares of company stock valued at $2,957,300 over the last 90 days. 0.30% of the stock is owned by corporate insiders.

Institutional Trading of CME Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its stake in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares during the period. Capital Advisors Ltd. LLC raised its stake in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares during the period. Lantz Financial LLC raised its stake in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after acquiring an additional 49 shares during the period. Transcend Capital Advisors LLC lifted its holdings in CME Group by 1.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after purchasing an additional 50 shares during the last quarter. Finally, Lester Murray Antman dba SimplyRich boosted its position in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.